SHORT COMMUNICATION
Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition
 
More details
Hide details
 
Publication date: 2015-12-21
 
 
BioTechnologia 2014;95(4):276-279
 
ABSTRACT
The object of the invention are 1) nucleotide analogues, 2) antiviral pro-nucleotides, 3) a use of nucleotide analogues and pharmaceutical composition, 4) a phosphorylating agent for synthesis of nucleotide analogue, and 5) a method of synthesis of nucleotide analogues. More precisely, the invention applies to the new group of nucleotide analogues and their use in partial or complete inhibition of human immunodeficiency virus (HIV).
REFERENCES (2)
1.
Romanowska J., Sobkowski M., Szymanska-Michalak A., Kolodziej K., Dąbrowska A., Lipniacki A., Piasek A., Pietrusiewicz Z.M., Figlerowicz M., Guranowski A., Boryski J., Stawinski J., Kraszewski A. (2011) Aryl H- Phosphonates.
 
2.
17: ( N- Aryl)phosphoramidates of Pyrimidine Nucleoside Analogues and Their Synthesis, Selected Properties, and Anti-HIV Activity. J. Med. Chem. 6482-6491.
 
eISSN:2353-9461
ISSN:0860-7796
Journals System - logo
Scroll to top